 |
            |
Abstract Submission
DEADLINE FOR RECEIPT OF ABSTRACTS: May
1, 2008
Online Abstract Submission is CLOSED
General Information
- The abstract must be written in English.
- Deadline: abstracts MUST BE RECEIVED no later than May
1, 2008.
- Online abstract submissions are required.
- Presenting authors must pay the registration fee and attend
the meeting. Authors of accepted abstracts are not provided with
travel funds.
- 5. All accepted abstracts for presentation who have registered
for the AKIN meeting will be included in the AKIN Conference Program
Syllabus that is distributed at the meeting
- 6. All accepted abstracts will be exhibited during the poster
sessions on Tuesday. June 10, 2008 (6:00PM).
- Notification of acceptance will be emailed by May 16, 2008.
Content of the Abstract
- Abstracts are limited to 500 words.
- Body of abstract: purpose of the study, methods used, summary of the results
and conclusion reached.
- Please try to limit your author list to 10.
- References and credits MUST NOT be included in the abstract.
- Simple tables may be made in the submission form - PLEASE DO NOT PASTE TABLES
IN THE ABSTRACT BODY.
- Formulas should be avoided.
- Use standard abbreviations in parentheses after the full word the first
time it appears.
- Please indicate the subject category your abstract most closely represents:
a) Pre-Clinical Research
b) Translational Research
c) Patient-Oriented Research
d) Drugs and Devices
- Abstracts will be published as submitted. Proof and edit your submission
accordingly.
Submission
- Many of the fields in the Abstract Form are required. Your form
will not submit until it is complete. Please press the submit
button only once.
- Notification of acceptance will be mailed by May 16,
2008.
- Upon acceptance, additional information will be forthcoming
regarding poster dimensions, preparation and presentation of your
poster.
- For additional information or if you are unable to complete
an online submission contact:
RES Seminars
4425 Cass Street, Suite A
San Diego, CA 92109
Email: res@res-inc.com
Tel: 858-272-1018
Fax: 858-272-7687
Online Abstract Submission is CLOSED
|
|
|